All In Biotech

Drug Trial Radar · NCT01678027

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

Helicobacter Pylori Eradication to Prevent Gastric Cancer in Subjects With Family History of Gastric Cancer: A Randomized Controlled Study

Last checked: Nov 20, 2026Latest source record: Nov 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,838 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,838

Actual

Start

Nov 2004

Primary completion

Dec 2018

Study completion Dec 2035

Sponsor

Lead sponsor
National Cancer Center, KoreaGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Sep 3, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study evaluate whether treatment of Helicobacter pylori infection reduces the incidence of gastric cancer in subjects with family history of gastric cancer.

Conditions

  • Gastric Cancer
  • Helicobacter Pylori Infection
  • Family Members

Interventions

  • PlaceboDrug

    Lansoprazole placebo, amoxicillin placebo, and clarithromycin placebo, all twice a day for 1 week.

  • LAC triple therapyDrug

    Lansoprazole 30 mg, amoxicillin 1,000 mg, and clarithromycin 500 mg, all twice a day for 1 week.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Gastric cancer incidenceTime frame: 6 years after last participant enrollment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Cancer Center, Korea

    Goyang-si, Gyeonggi-do, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.